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The  objective  of  this  randomized,  blinded,  placebo  controlled  laboratory  study  was  to
conﬁrm the  efﬁcacy  of a single  oral  administration  of two  marketed  formulations  of  milbe-
mycin oxime  (Interceptor® Flavor  Tabs® and  Sentinel® Flavor  Tabs®) at  a minimum  dose  of
0.5 mg/kg  (0.23  mg/lb)  against  natural  infections  of  Ancylostoma  braziliense  in  dogs.  Thirty-
six hookworm  infected  dogs,  a  minimum  of  10  weeks  of age  and  of various  breeds  and
genders were  used.  Fecal  egg  counts  were  done  on three  separate  days  prior  to  treatment
for randomization  purposes.  Dogs  were  ranked  by  descending  order  of the fecal  egg  count
arithmetic  means  and  randomly  assigned  to either  the  two  milbemycin  treatment  groups
or the placebo  control  group  in  blocks  of  three  dogs  each,  12  dogs  per group.  Dogs  were
dosed according  to the  product  label  with  blinding  maintained  by separation  of function.
Worm  counts  were  done  at necropsy  7 days  after  treatment.  Reduction  in  A.  braziliense
worm  counts  in  the milbemycin  groups  were  compared  to the  placebo  control  group  using
analysis of  variance  of  the  A. braziliense  logarithmic  mean  worm  counts  and  percent  efﬁcacy
was  based  on  geometric  means.  Efﬁcacy  was  deﬁned  as  the  ability  of the  test  products  to  sig-
niﬁcantly  (p ≤ 0.05)  reduce  parasite  load  by  90%  or  greater  in  treated  dogs  when  compared
to adequately  infected  placebo  control  dogs.  The placebo  control  group  had  a geometric
mean  worm  count  of  19.2.  The  Interceptor  treated  group  had a  geometric  mean  worm
count  of  0.38  representing  a 98%  reduction  in parasite  load  and  the  Sentinel  treated  group
had  a  geometric  mean  worm  count  of  0.98  representing  a 95%  reduction  in  parasite  load.
Both reductions  were  highly  signiﬁcant  (p  <  0.0001).  In  this  study,  milbemycin  oxime,  when
administered  as two  marketed  formulations  at a minimum  dose  of  0.5  mg/kg  (0.23  mg/lb),
was efﬁcacious  for removing  adult A. braziliense  in  naturally  infected  dogs.. Introduction
Ancylostoma braziliense is a pathogenic hookworm para-
ite of dogs most generally associated with warm and moist
limates. Although not as pathogenic as Ancylostoma can-
num, heavy infections in young dogs may  result in blood
oss (Rep, 1980) and hypoproteinemia (Miller, 1968). How-
ver, the most signiﬁcant concern with A. braziliense is
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its ability to cause cutaneous larva migrans in both dogs
(Vetter and Leegwater-vd Linden, 1977; Vetter and van
der Linden, 1977a,b; Bowman et al., 2010) and humans
(Brenner and Patel, 2003; Patel et al., 2008; Purdy et al.,
2011). Of the hookworm larvae, A. braziliense tends to be
more invasive by cutaneous penetration and shows the
greatest enzyme activity for breaking down structures of
the skin (Hotez et al., 1992), thus allowing the larvae to
Open access under CC BY-NC-ND license.enter by direct contact with intact skin and mucous mem-
branes. Not only has A. braziliense been associated with
cutaneous larva migrans in humans, but also migration to
the lungs (Butland and Coulson, 1985) and oral mucosa
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(Damante et al., 2011). Even though the parasite is more
common in the tropical regions of the world, it has also
been reported in non tropical settings (Herbener and Borak,
1988), suggesting the need for control outside the areas
typically considered endemic. Therefore, effective control
of A. braziliense in dogs is important because of its potential
pathogenicity in dogs and zoonotic potential for cutaneous
larva migrans in humans.
Milbemycin oxime is a macrocyclic lactone that is
efﬁcacious against infections of A. caninum (Blagburn
et al., 1992; Niamatali et al., 1992), but no studies have
been done speciﬁcally investigating effectiveness against
A. braziliense.  We  hypothesized that milbemycin oxime
would be over 90% efﬁcacious when administered as a sin-
gle treatment to dogs infected with A. braziliense.
2. Materials and methods
The study was a randomized, blinded, placebo con-
trolled laboratory study using naturally infected dogs
conducted in compliance with GCP (VICH GL9), South
African animal welfare regulations, as stipulated in the
“National Code for Animal Use in Research, Education,
Diagnosis and Testing of Drugs and Related Substances in
South Africa”. The protocol was submitted to the ClinVet
Animal Ethics Committee (CAEC), the composition of which
was in compliance with the National Code, for approval. In
addition, the protocol was reviewed and approved by the
Novartis Animal Health US, Inc. Institutional Animal Care
and Use Committee.
2.1. Animals
Thirty-six hookworm infected dogs (21 males and 15
females), a minimum of 10 weeks of age and of any pure
or mixed breed were randomly assigned to cages at the
beginning of acclimation. Animals were purchased from
owners who were fully informed of the nature of the
study. Each dog was identiﬁed by a unique number on
a collar tag. All purchase contracts indicated each ani-
mal’s origin and procurement records traceable to each
animal by identiﬁcation number. Individual dog pens were
marked with corresponding animal identiﬁcation num-
bers. Potential infection with A. braziliense was assessed
by fecal egg counts (presence of hookworm eggs) for
three consecutive days prior to inclusion in the study.
A sample of dogs from a speciﬁc source were acquired
for necropsy purposes to conﬁrm the presence of A.
braziliense. Other than intestinal parasitism, dogs were
clinically healthy as determined by a general physical
examination and clinical pathology review. Dogs were
acclimated at least 7 days prior to treatment and were
observed at least once daily up to the time of treat-
ment.
2.2. HousingDogs were housed individually. Room temperature was
monitored and exercise was conducted according to facil-
ity standard operating procedures, as appropriate. Animals
were acclimated at least seven days prior to treatment andtology 195 (2013) 102– 105 103
were observed at least once daily up to the time of treat-
ment and then twice daily until euthanasia. A commercially
available high quality complete canine diet, which pro-
vided the nutritional requirements for the age of dog used
in this study was  offered ad libitum to each dog. Water was
also available ad libitum.
2.3. Randomization
Fecal egg counts were done using the McMaster tech-
nique (Henriksen and Aagaard, 1976) on three separate
days prior to treatment for randomization purposes. Dogs
were ranked by descending order of the fecal egg count
arithmetic means and randomly assigned to treatment
in blocks of three dogs each (one dog to each treatment
group), 12 dogs per group. Randomizations were per-
formed in two replicates (phases), with each replicate
group containing 18 dogs. The randomization process was
applied independently within each replicate. Counts were
recorded as hookworm eggs per gram of feces (epg) with
subsequent determination of arithmetic means by a statis-
tician.
2.4. Blinding
Blinding was  accomplished by separation of function.
Individuals responsible for general health observations,
clinical observations, or examination of dogs at necropsy
for adult A. braziliense worms did not know the allocation
of dogs to treatment. Only the statistician and individuals
responsible for drug administration were aware of treat-
ment assignments until analyses.
2.5. Procedures
All dogs were fasted overnight before the day of
treatment to encourage food intake prior to dosing and
treatment was  administered within approximately 30 min
after feeding. Dogs received either a single oral adminis-
tration of the marketed formulations of milbemycin oxime
(Interceptor® Flavor Tabs® or Sentinel® Flavor Tabs®;
Novartis Animal Health US, Inc.) according to the label at
a minimum dose of 0.5 mg/kg (0.23 mg/lb) or a placebo
(Pet-Tabs®; Virbac Animal Health, Inc.). Observations for
adverse clinical signs were done on each dog within 1 h
(±15 min) prior to treatment and again at 1, 4, 8 h (±15 min)
and 24 h (±1 h) after treatment. Seven days after treat-
ment each dog was administered a lethal intravenous dose
of euthanasia solution (Euthapent®; Kyron Laboratories
[Pty] Ltd) in the same order as treatment group assign-
ment for assessing adult worm counts in the intestinal
tract. The dose of euthanasia solution was based on the
body weight determined on the day of euthanasia. Dogs
were fasted 12 h immediately prior to euthanasia in order
to decrease the amount of material in the intestinal tract.
The abdominal cavity was opened along the ventral mid-
line and double ligatures were placed at the cardia of
the stomach and at the distal rectum prior to removal of
the gastrointestinal tract from the abdominal cavity. The
stomach was opened along the greater curvature and the
contents collected in a suitable container. The mucosa was
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horoughly scrubbed, rinsed with water and the wash-
ngs combined with the gastric contents. The mucosa was
nspected and any attached parasites were removed and
reserved in 10% formalin or other suitable preservative.
n a similar manner, the small and large intestines were
pened along their entire length and the contents and
ucosa were collected, thoroughly rinsed with water and
he scrapings/washings from the mucosa were combined.
he mucosa was inspected and any attached parasites
ere removed and preserved in 10% formalin. The gas-
ric and intestinal contents and rinsing ﬂuids were washed
ver appropriately sized sieve(s) and any material that
etained in the sieve(s) was preserved in 10% forma-
in.
.6. A. braziliense identiﬁcation
Worm recovery and identiﬁcation were performed by
ppropriately trained and experienced individuals. Prior to
xamining the preserved worms and washings, formalin
as removed by sedimentation and/or washing. Recovered
orms were examined microscopically, identiﬁed to genus
nd species based on characteristics of the buccal plates.
he number of adult A. braziliense recovered from each dog
as recorded along with the number of other adult worms
ecovered from each dog.
.7. Statistical analyses
Twelve dogs were randomized to each group to increase
he probability of having at least six dogs adequately
nfected in the placebo control group indicating an ade-
uate test. The individual dog was the experimental unit.
fﬁcacy was determined on the basis of the percent
eduction in adult worm counts in the treated groups
ompared to the placebo control group. Arithmetic and
eometric means of all A. braziliense counts were calcu-
ated.
Percent effectiveness was calculated using the following
ormula:
ercent Effectiveness = 100 ∗
(
cc − ct
cc
)
here cc = geometric mean number of adult A. braziliense
n the control group and ct = geometric mean number of
dult A. braziliense in the treatment group. There were
eparate calculations for each treatment group. Since the
alculation of the geometric mean involved taking the log-
rithm of the A. braziliense count of each animal, a “1”
as added to the A. braziliense count for every animal in
very group since there were A. braziliense counts equal
o zero. This constant (1) was subtracted from the resul-
ant calculated geometric mean prior to calculating percent
ffectiveness. Percent effectiveness based on ≥90% reduc-
ion in A. braziliense worm burden was calculated using
eometric means. All analyses were performed on logarith-
ic  means using SAS/STAT® software (Version 9 of the SAS
ystem for Windows, SAS Institute Inc.) and all hypotheses
ere tested at a two-sided 0.05 level of signiﬁcance.itology 195 (2013) 102– 105
3. Results
Of the 36 dogs enrolled in the study, 21 were male
and 15 were female (Placebo = 5 males and 7 females;
Interceptor = 8 males and 4 females; Sentinel = 8 males
and 4 females). Dogs treated with Interceptor or Sentinel
received a mean milbemycin oxime dose of 0.57 ± 0.08 and
0.57 ± 0.05 mg/kg, respectively. All dogs were reported as
being over 10 months of age and the weight ranged from
4.7 to 21.3 kg two  days prior to dosing (weight used to
determine dose). There were no signiﬁcant differences in
body weights between treatment groups. Breeds repre-
sented were variable and included purebred and mixed
Alsatians (German Shepherds), South African Boerboels,
Border Collies, Chihuahuas, Dachshunds, Dobermans,
Greyhounds, Labradors, Maltese, Ridgebacks, Rottweilers
and Terriers. Adult worms other than A. braziliense that
were identiﬁed during necropsy included A. caninum,
Uncinaria stenocephala, Trichuris vulpis, Toxocara canis,
Toxascaris leonina, Dipylidium caninum, Taenia spp. and
Echinococcus granulosus.  Efﬁcacy against these parasites
was  consistent with label indications.
Of the 12 dogs in the placebo control group, seven had
more than 20 A. braziliense isolated at necropsy and 10 had
more than ﬁve isolated at necropsy (range 10–100) indi-
cating the presence of an adequate infection in the study
dogs. Statistically, both milbemycin treatment groups had
signiﬁcantly (p < 0.0001) fewer A. braziliense isolated at
necropsy when compared to the placebo control group.
All surviving A. braziliense were isolated from the small
intestines. The calculated efﬁcacy based on geometric
means was  98.02% for the Interceptor® group and 94.91%
for the Sentinel® group (Table 1). Despite careful and
frequent observations of the study animals, no adverse
events, abnormal clinical observations, or abnormal health
observations were observed during the study. In addition,
there were no statistically signiﬁcant differences in body
weight change between groups.
4. Discussion
Macrocyclic lactones have excellent antihelmintic
activity and have been shown to be effective against hook-
worm infections in dogs and cats (Anderson and Roberson,
1982; Blagburn et al., 1992; Niamatali et al., 1992; Nolan
et al., 1992; Six et al., 2000). Milbemycin oxime is a macro-
cyclic lactone that is efﬁcacious against infections of A.
caninum (Blagburn et al., 1992; Niamatali et al., 1992), but
no studies have been done speciﬁcally investigating effec-
tiveness against A. braziliense,  as has been done for other
compounds (Robinson et al., 1976; Anderson and Roberson,
1982). In this study, we speciﬁcally investigated the effec-
tiveness of a single oral administration of milbemycin
oxime in two commercial formulations (Interceptor® Fla-
vor Tabs® and Sentinel® Flavor Tabs®) at a minimum
dose of 0.5 mg/kg (0.23 mg/lb) against natural infections of
A. braziliense in dogs. We  hypothesized that milbemycin
oxime would be over 90% efﬁcacious when administered
as a single treatment. Naturally infected dogs from South
Africa were used as A. braziliense is known to be endemic
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Table  1
Ancylostoma braziliense geometric mean counts, percent efﬁcacy and statistical signiﬁcance by treatment group.
Treatment group Geometric mean Arithmetic mean % Efﬁcacya p-Value
Placebo control 19.227 35.500 NA NA
Interceptor® Flavor Tabs® 0.381 0.583 98.02 <0.0001*
® ® *
ared to Sentinel Flavor Tabs 0.979 
a Percent efﬁcacy based on geometric means.
* Statistically signiﬁcant at p ≤ 0.05 when geometric means were comp
to this area (Verster, 1979; Minnaar and Krecek, 2001;
Minnaar et al., 2002).
The study design was based on the known life-cycle of
A. braziliense and is routinely used to determine the efﬁ-
cacy of anthelmintics in well controlled laboratory settings.
Thirty-six clinically healthy dogs (other than intestinal par-
asitism) of various breeds and body weights that were
a minimum of 10 weeks of age were used and were
representative of the general dog population present in
South Africa. Statistically, both of the milbemycin oxime
treatment groups had signiﬁcantly (p < 0.0001) fewer A.
braziliense isolated at necropsy when compared to the
placebo control group with reductions ranging from 94.91%
(Sentinel) to 98.02% (Interceptor) from a single admin-
istration. Taken together, these results conﬁrm that all
requirements for an adequate test of efﬁcacy were met  in
this study.
No adverse events were reported nor were there any
signiﬁcant reductions in body weight observed indicating
milbemycin oxime in these formulations was well toler-
ated, which is consistent with previous studies that have
shown milbemycin oxime is safe when administered orally
for control of nematode parasites (Ide et al., 1993).
5. Conclusion
This study demonstrates milbemycin oxime, when
administered in the commercial formulations of
Interceptor® Flavor Tabs® and Sentinel® Flavor Tabs®
at a minimum milbemycin oxime dose of 0.5 mg/kg
(0.23 mg/lb), is efﬁcacious for the removal and control of
adult A. braziliense in dogs.
Acknowledgement
The authors thank Dr. Barry Hyman for his oversight
during the conduct of the study.
References
Anderson, D.L., Roberson, E.L., 1982. Activity of ivermectin against canine
intestinal helminths. Am.  J. Vet. Res. 43, 1681–1683.
Blagburn, B.L., Hendrix, C.M., Lindsay, D.S., Vaughan, J.L., Hepler, D.I.,
Wright, J.C., 1992. Efﬁcacy of milbemycin oxime against naturally
acquired or experimentally induced Ancylostoma spp. and Trichuris
vulpis infections in dogs. Am.  J. Vet. Res. 53, 513–516.Bowman, D.D., Montgomery, S.P., Zajac, A.M., Eberhard, M.L., Kazacos,
K.R., 2010. Hookworms of dogs and cats as agents of cutaneous larva
migrans. Trends Parasitol. 26, 162–167.
Brenner, M.A., Patel, M.B., 2003. Cutaneous larva migrans: the creeping
eruption. Cutis 72, 111–115.2.167 94.91 <0.0001
Placebo.
Butland, R.J.A., Coulson, I.H., 1985. Pulmonary eosinophilia associated with
cutaneous larva migrans. Thorax 40, 76–77.
Damante, J.H., Chinellato, L.E.M., de Oliveira, F.T., Soares, C.T., Fleury, R.N.,
2011. Larva migrans in the oral mucosa: report of two cases. Braz.
Dent. J. 22, 166–170.
Henriksen, S.A., Aagaard, K.A., 1976. A simple ﬂotation and McMaster
method. Nord. Vet. Med. 28, 392–397.
Herbener, D., Borak, J., 1988. Cutaneous larva migrans in northern cli-
mates. Am.  J. Emerg. Med. 6, 262–264.
Hotez, P.J., Narasimhan, S., Haggerty, J., Milstone, L., Bhopale, V., Schad,
G.A., Richards, F.F., 1992. Hyaluronidase from infective Ancylostoma
hookworm larvae and its possible function as a virulence factor in
tissue invasion and in cutaneous larva migrans. Infect. Immun. 60,
1018–1023.
Ide, J., Okazaki, T., Ono, M.,  Saito, A., Nakagawa, K., Naito, S., Sato, K., Tanaka,
K.,  Yoshikawa, H., Ando, M.,  Katsumi, S., Matsumoto, K., Toyama, T.,
Shibano, M.,  Abe, M.,  1993. Milbemycin: discovery and development.
Annu. Rep. Sanko. Res. Lab. 45, 1–98.
Miller, T.A., 1968. Pathogenesis and immunity in hookworm infection.
Trans. R. Soc. Trop. Med. Hyg. 62, 473–489.
Minnaar, W.N., Krecek, R.C., 2001. Helminths in dogs belonging to peo-
ple in a resource-limited urban community in Gauteng, South Africa.
Onderstepoort J. Vet. Res. 68, 111–117.
Minnaar, W.N., Krecek, R.C., Fourie, L.J., 2002. Helminths in dogs from a
peri-urban resource-limited community in Free State Province. South
Africa. Vet. Parasitol. 107, 343–349.
Niamatali, S., Bhopale, V., Schad, G.A., 1992. Efﬁcacy of milbemycin
oxime against experimentally induced Ancylostoma caninum and
Uncinaria stenocephala infections in dogs. J. Am.  Vet. Med. Assoc. 201,
1385–1387.
Nolan, T.J., Niamatali, S., Bhopale, V., Longhofer, S.L., Schad, G.A., 1992. Efﬁ-
cacy of a chewable formulation of ivermectin against a mixed infection
of  Ancylostoma braziliense and Ancylostoma tubaeforme in cats. Am. J.
Vet. Res. 53, 1411–1413.
Patel, S., Aboutalebi, S., Vindhya, P.L., Smith, J., 2008. What’s eating you?
Extensive cutaneous larva migrans (Ancylostoma braziliense). Cutis 82,
239–240.
Purdy, K.S., Langley, R.G., Webb, A.N., Walsh, N., Haldane, D., 2011. Cuta-
neous larva migrans. Lancet 377, 1948.
Rep, B.H., 1980. Pathogenicity of hookworms, the signiﬁcance of popula-
tion regression for the pathogenicity of hookworms. Trop. Geogr. Med.
32, 251–255.
Robinson, M.,  Hooke, F.G., Iverson, K.E., 1976. Efﬁcacy of pyrantel pamoate
and piperazine citrate against roundworm and hookworm species in
dogs. Aust. Vet. Pract. 6, 104–108.
Six, R.H., Sture, G.H., Thomas, C.A., Clemence, R.G., Benchaoui, H.A.,
Boy, M.G., Watson, P., Smith, D.G., Jernigan, A.D., Rowan, T.G., 2000.
Efﬁcacy and safety of selamectin against gastrointestinal nema-
todes in cats presented as veterinary patients. Vet. Parasitol. 91,
321–331.
Verster, A., 1979. Gastro-intestinal helminths of domestic dogs in the
Republic of South Africa. Onderstepoort J. Vet. Res., 79–82.
Vetter, J.C., Leegwater-vd Linden, M.E., 1977. Skin penetration of infective
hookworm larvae. III. Comparison studies on the path of migration of
the hookworms Ancylostoma braziliense,  Ancylostoma ceylanicum, and
Ancylostoma caninum. Z. Parasitenkd. 53, 155–158.
Vetter, J.C., van der Linden, M.E., 1977a. Skin penetration of infective hook-
worm larvae. I. The path of migration of infective larvae of Ancylostoma
braziliense in canine skin. Z. Parasitenkd. 53, 255–262.
Vetter, J.C., van der Linden, M.E., 1977b. Skin penetration of infective
hookworm larvae. II. The path of migration of infective larvae of Ancy-
lostoma braziliense in the metacarpal foot pads of dogs. Z. Parasitenkd.
53,  263–266.
